(AstraZeneca) shares rose 1% after a breast cancer drug developed jointly with Daiichi Sankyo was approved by the US Food and Drug Administration.

Zhitongcaijing · 2d ago
(AstraZeneca) shares rose 1% after a breast cancer drug developed jointly with Daiichi Sankyo was approved by the US Food and Drug Administration.